Bally's presents an unusual situation: rather than a set of bullish targets sitting comfortably above the stock, the most recent analyst price targets fall below the market price. After the company's second-quarter report in August 2026, Macquarie trimmed its target to $11 (Neutral), Truist Financial lowered its target to $10 (Hold), and Barclays reduced its target to $7 (Underweight). Stifel kept its $13 (Hold) rating. Collectively, the latest individual targets span roughly $7 to $13, with a mean near $10 to $11—below the recent price of about $12.
Because no current, credible analyst target stands meaningfully above the price, a conventional average analyst price target would land below where the stock already trades, offering little useful reference. The $15 level used here therefore reflects public discussion rather than an analyst consensus: it is the round-number recovery milestone that would return the stock toward the higher end of the objectives analysts cited earlier in 2026, before the going-concern disclosure. It should not be read as a published or consensus forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Bally's Corporation (BALY) is a global casino, hospitality, and interactive gaming company with roughly 20 casinos across 11 U.S. states and one in the U.K., plus sports betting, iCasino, and a majority stake in lottery operator Intralot. With the stock near $12 and a market capitalization around $600 million, reaching $15 would represent about a 25% gain—a substantial move that would still leave the shares well below their 52-week high of roughly $19.60 to $20.74.
The path to $15 would likely require resolving the concerns that have driven the stock down. The company reported strong top-line momentum—preliminary third-quarter 2026 revenue of $807.6 million, up 21.7% year over year—but profitability remains negative, and the August quarter included a "going concern" disclosure that triggered a sharp sell-off of more than 25% in a single session. Regaining investor confidence in liquidity and debt reduction is central to any recovery in the share price.
Bally's most compelling support is its revenue growth and development pipeline. Quarterly revenue has been rising in the 20% to 28% range year over year, helped by organic gains and the completed acquisition of Queen Casino & Entertainment. The company has secured substantial financing tied to growth projects, including a commitment from Gaming and Leisure Properties covering much of the cost of the Chicago casino and a term loan package for the Bronx development. Sale-leaseback transactions on properties in Kansas City, Shreveport, and Twin River Lincoln have also raised cash to fund these projects.
If management can demonstrate progress toward positive adjusted cash flow, reduced leverage, and on-schedule project openings, the narrative could shift from distress to a turnaround, supporting a re-rating of the shares toward levels analysts cited earlier in the year.
The obstacles are substantial. Lease-adjusted leverage has been cited near 6.5 times EBITDA, among the highest in gaming coverage, and the company carries a sub-investment-grade credit profile. The going-concern warning, a CFO resignation, delayed 10-Q filings, and shareholder investigations into potential securities claims all weigh on sentiment. Net losses, negative operating cash flow, and large development commitments leave limited room for error. If liquidity concerns resurface or project timelines slip, the stock could remain under pressure rather than recover.
From a technical standpoint, the shares have been volatile, trading between a 52-week low near $8.44 and a high near $19.60 to $20.74. The stock sits below its 50-day moving average of roughly $12.47 and its 200-day moving average near $12.77—levels that have acted as resistance during recent rallies. A durable push toward $15 would likely need to clear the $13 area first, a prior analyst-target zone and round-number resistance level. On the downside, the $8.44 low is the key support level to watch. I reviewed recent patterns here with Tickeron’s AI Real Time Patterns for additional context.
Analyst price targets typically reflect a roughly 12-month research horizon, though Bally's coverage has been revised repeatedly, so individual timeframes differ. Investors should watch the next earnings report and any guidance on liquidity, the resolution of delayed filings, refinancing or deleveraging activity, construction milestones in Chicago and the Bronx, and any updates on the shareholder investigations. Analyst revisions have been frequent and materially negative, so further target changes are a key signal for the market outlook.
Can Bally's Corporation (BALY) reach $15? The question hinges on a turnaround that has not yet been demonstrated. The $15 level is a recovery milestone drawn from public discussion and earlier, higher analyst objectives—not a current consensus, since the latest targets of $7 to $13 sit at or below the price. Reaching $15 would require about a 25% gain, driven by sustained revenue growth, progress on deleveraging, and restored confidence in the company's financial footing. The principal obstacles—the going-concern disclosure, heavy leverage, leadership turnover, delayed filings, and ongoing investigations—are significant. Investors should monitor liquidity, earnings, project execution, and analyst revisions rather than treat $15 as a guaranteed outcome.
In my own research process, I frequently consult Tickeron's AI Daily Buy/Sell Signals for a data-driven complement to fundamental work. The system applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on shifting market conditions and technical behavior. It helps me spot opportunities and track trends more efficiently in volatile names like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Aroon Indicator for BALY entered a downward trend on November 10, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 241 similar instances where the Aroon Indicator formed such a pattern. In 210 of the 241 cases the stock moved lower. This puts the odds of a downward move at 87%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BALY as a result. In 74 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for BALY turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
BALY moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BALY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where BALY advanced for three days, in 162 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
BALY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.969) is normal, around the industry mean (14.575). P/E Ratio (-0.817) is within average values for comparable stocks, (53.870). Projected Growth (PEG Ratio) (0.050) is also within normal values, averaging (0.784). Dividend Yield (0.032) settles around the average of (0.022) among similar stocks. P/S Ratio (0.222) is also within normal values, averaging (1.049).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. BALY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BALY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of gaming and racing facilities
Industry HotelsResortsCruiselines